Movatterモバイル変換

[0]ホーム
URL:

DOP2009000047A - TIAZOL PIRAZOLOPIRIMIDINAS AS ANTAGONISTS OF THE CRF1 RECEIVER - Google Patents

TIAZOL PIRAZOLOPIRIMIDINAS AS ANTAGONISTS OF THE CRF1 RECEIVER

Info

Publication number
DOP2009000047A
DOP2009000047ADO2009000047ADO2009000047ADOP2009000047ADO P2009000047 ADOP2009000047 ADO P2009000047ADO 2009000047 ADO2009000047 ADO 2009000047ADO 2009000047 ADO2009000047 ADO 2009000047ADO P2009000047 ADOP2009000047 ADO P2009000047A
Authority
DO
Dominican Republic
Prior art keywords
crf1
antagonists
pirazolopirimidinas
tiazol
receiver
Prior art date
Application number
DO2009000047A
Other languages
Spanish (es)
Inventor
Chafiq Hamdouchi Hamdouchi
Zhaogen Chen
Erik James Hembre
Philip Arthur Hipskind
Jason Kenneth Myers
Takako Takakuwa
James Lee Toth
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co ElifiledCriticalLilly Co Eli
Priority to DO2009000047ApriorityCriticalpatent/DOP2009000047A/en
Publication of DOP2009000047ApublicationCriticalpatent/DOP2009000047A/en

Links

Landscapes

Abstract

Translated fromSpanish

La primera invención se refiere a compuestos de Fórmula I: composiciones farmacéuticas de los mismos, y al uso de tales compuestos como antagonistas del receptor del factor 1 de liberación de corticotropina (CRF1), en el tratamiento de trastornos psiquíatricos y neuroendocrinos, enfermedades neurólogicas y síndrome metabólicos.The first invention relates to compounds of Formula I: pharmaceutical compositions thereof, and to the use of such compounds as antagonists of the corticotropin-releasing factor 1 receptor (CRF1), in the treatment of psychiatric and neuroendocrine disorders, neurological diseases and metabolic syndrome

DO2009000047A2009-03-172009-03-17 TIAZOL PIRAZOLOPIRIMIDINAS AS ANTAGONISTS OF THE CRF1 RECEIVERDOP2009000047A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
DO2009000047ADOP2009000047A (en)2009-03-172009-03-17 TIAZOL PIRAZOLOPIRIMIDINAS AS ANTAGONISTS OF THE CRF1 RECEIVER

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
DO2009000047ADOP2009000047A (en)2009-03-172009-03-17 TIAZOL PIRAZOLOPIRIMIDINAS AS ANTAGONISTS OF THE CRF1 RECEIVER

Publications (1)

Publication NumberPublication Date
DOP2009000047Atrue DOP2009000047A (en)2009-04-30

Family

ID=44261554

Family Applications (1)

Application NumberTitlePriority DateFiling Date
DO2009000047ADOP2009000047A (en)2009-03-172009-03-17 TIAZOL PIRAZOLOPIRIMIDINAS AS ANTAGONISTS OF THE CRF1 RECEIVER

Country Status (1)

CountryLink
DO (1)DOP2009000047A (en)

Similar Documents

PublicationPublication DateTitle
CR10682A (en) TIAZOL PIRAZOLOPIRIMIDINE COMPOUNDS
MX2021006804A (en) POLYCYCLIC ANTAGONISTS OF THE TOLL-TYPE 7/8 RECEPTOR (TLR7/8) AND THEIR USE IN THE TREATMENT OF IMMUNE DISORDERS.
CO6382124A2 (en) CCR2 RECEIVER ANTAGONISTS AND USES OF THE SAME
MX2015013711A (en) NOVEDOSAS N-ACIL- (3-SUBSTITUTES) - (8-SUBSTITUTES) -5,6-DIHIDRO- [1,2,4] TRIAZOLO [4,3-A] PYRACINES AS SELECTED ANTAGONISTS OF NK-3 RECEPTOR, COMPOSITION PHARMACEUTICS AND METHODS FOR USE IN DISORDERS MEDIATED BY THE NK-3 RECEIVER.
MX346393B (en) NEW ANTAGONISTS OF THE CCR2 RECEIVER AND USES OF THE SAME.
EA201490912A1 (en) DERIVATIVES [1,2,3] TRIAZOLO [4,5-D] Pyrimidine as Agonists of Cannabinoid Receptor 2
CL2008001632A1 (en) Compounds derived from substituted benzoylamino-indan-2-carboxylic acids, inhibitors of the cxcr5 receptor; pharmaceutical composition; and its use in the treatment of inflammatory physiological effects, such as rheumatoid arthritis and asthma.
CU20100159A7 (en) COMPOUNDS
MX388468B (en) MULTICYCLIC COMPOUNDS AND METHODS OF USING THEM.
CO6361994A2 (en) ISONICOTINAMIDE OREXINE RECEIVER ANTAGONISTS
UY32629A (en) ANTIVIRAL COMPOUNDS, COMPOSITIONS AND USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF ASSOCIATED DISORDERS WITH HEPATITIS C.
EA201290940A1 (en) NEW CONNECTIONS AS SELECTIVE ANTAGONISTS OF NK3 RECEPTOR, PHARMACEUTICAL COMPOSITION AND METHODS OF THEIR USE FOR DAMAGE MEDIATED BY NK3 RECEPTORS
EA201490579A1 (en) NEW CHIRAL N-ACYL-5,6,7, (8-SUBSTITUTED) TETRAHYDRO- [1,2,4] TRIAZOLO [4,3-A] PIRASINS AS A SELECTIVE ANTAGONISTS OF RECEPTOR NK-3, PHARMACEUTICAL COMPOSITION AZERTHIGRAPHIHIHIIHIIHIIJRI OCI-ZA, OTTRAHYDRO-NI-ZA, NI-ZI-3 , MEDIATED NK-3 RECEPTORS, AND THEIR CHARAL SYNTHESIS
UY34530A (en) ANTAGONISTS OF THE TRANSITORY POTENTIAL VANILLOID RECEIVER 1 (TRPV1)
MX370017B (en)Heterobicyclo-substituted-[1,2,4]triazolo[1,5-c]quinazolin-5-ami ne compounds with a2a antagonist properties.
UY32968A (en) FUSIONED HETEROCYCLIC COMPOUNDS AS OREXINE RECEIVER MODULATORS
DOP2011000271A (en) DERIVATIVES OF INDOL AS AN ANTHOGONIST OF THE CRTH2 RECEIVER
CR20110621A (en) 3- [4- (7H-PIRROLO [2,3-D] PIRIMIDIN-4-IL) 1H-PIRAZOL-1-IL] OCTANO-O HEPTANO-NITRILO AS JAK INHABITORS
UY32574A (en) CXCR3 RECEIVER ANTAGONISTS
EA201190017A1 (en) AMINO ETHER DERIVATIVES OF ALKALOIDS AND THEIR MEDICAL COMPOSITIONS
MX2011010449A (en)Oxadiazole derivatives.
EA201100161A1 (en) QUINUCLIDINE CARBONATE DERIVATIVES AND THEIR MEDICAL COMPOSITIONS
CL2007001711A1 (en) Compounds derived from substituted pyrazolopyridine; pharmaceutical composition comprising them; method of preparation of the compounds, intermediates; and their use in the treatment of diseases, such as tumors, rheumatoid arthritis, diseases of deregulated vascular growth, among others.
MX390264B (en) D2 ANTAGONISTS, SYNTHESIS METHODS AND METHODS OF USE.
CL2012000967A1 (en) Compounds derived from amide of indazole-4-carboxylic acids and 1-h-pyrazolo [3,4-c] pyridine-4-carboxylic acids, agonists of the ccr1 receptor; pharmaceutical composition; Useful in the treatment of chronic inflammations, allergies, psoriasis, rheumatoid arthritis, multiple sclerosis, type 1 diabetes, among others.
[8]ページ先頭
©2009-2025 Movatter.jp